Angelica D'Aiello - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Cancers|February 11, 2023

Advances in the Management of Central Nervous System Metastases in Non-Small Cell Lung CancerAngelica D'Aiello, Emily Miao, Haiying Cheng

Journal of Thoracic Disease|July 10, 2019

Changes in store for early-stage non-small cell lung cancerJason E Sandler, Angelica D'Aiello, Balazs Halmos

Clinical Lung Cancer|March 10, 2024

Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New ChallengesAngelica D'Aiello, Brendon Stiles, Nitin Ohri, et al.

Pathology Oncology Research : POR|July 3, 2024

Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discoveryHyein Jeon, Rajvi Gor, Angelica D'Aiello, et al.

Journal of the American Academy of Dermatology|June 13, 2026

Considerations for Commonly Prescribed Medications by Dermatologists in Patients on Immune Checkpoint InhibitorsCarolyn Rachofsky, Mei Hong Liu, Angelica D'Aiello, et al.

Cancers|April 3, 2021

Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban CohortAngelica D'Aiello, Juan Lin, Rasim Gucalp, et al.

Journal of Gastrointestinal Cancer|May 9, 2022

Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes in a Racially Diverse Urban PopulationAngelica D'Aiello, Numa Rahman, N Patrik Brodin, et al.

Frontiers in Oncology|July 28, 2023

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancerQiyu Fang, Xiaoying Wan, Angelica D'Aiello, et al.

Cancers|May 14, 2025

Chemotherapy-Free Treatment with Radiotherapy and Immunotherapy for Locally Advanced Non-Small Cell Lung CancerM Zeeshan Ozair, Balazs Halmos, Angelica D'Aiello, et al.

NPJ Precision Oncology|January 27, 2026

Treatment adherence and clinical outcomes of osimertinib in minority patients with advanced EGFR mutated NSCLCMatthew Lee, Junmin Song, Emily Miao, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Cancers|February 11, 2023

Advances in the Management of Central Nervous System Metastases in Non-Small Cell Lung CancerAngelica D'Aiello, Emily Miao, Haiying Cheng

Journal of Thoracic Disease|July 10, 2019

Changes in store for early-stage non-small cell lung cancerJason E Sandler, Angelica D'Aiello, Balazs Halmos

Clinical Lung Cancer|March 10, 2024

Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New ChallengesAngelica D'Aiello, Brendon Stiles, Nitin Ohri, et al.

Pathology Oncology Research : POR|July 3, 2024

Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discoveryHyein Jeon, Rajvi Gor, Angelica D'Aiello, et al.

Journal of the American Academy of Dermatology|June 13, 2026

Considerations for Commonly Prescribed Medications by Dermatologists in Patients on Immune Checkpoint InhibitorsCarolyn Rachofsky, Mei Hong Liu, Angelica D'Aiello, et al.

Cancers|April 3, 2021

Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban CohortAngelica D'Aiello, Juan Lin, Rasim Gucalp, et al.

Journal of Gastrointestinal Cancer|May 9, 2022

Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes in a Racially Diverse Urban PopulationAngelica D'Aiello, Numa Rahman, N Patrik Brodin, et al.

Frontiers in Oncology|July 28, 2023

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancerQiyu Fang, Xiaoying Wan, Angelica D'Aiello, et al.

Cancers|May 14, 2025

Chemotherapy-Free Treatment with Radiotherapy and Immunotherapy for Locally Advanced Non-Small Cell Lung CancerM Zeeshan Ozair, Balazs Halmos, Angelica D'Aiello, et al.

NPJ Precision Oncology|January 27, 2026

Treatment adherence and clinical outcomes of osimertinib in minority patients with advanced EGFR mutated NSCLCMatthew Lee, Junmin Song, Emily Miao, et al.

Pageof 2